Paper41587271
Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
Armstrong A and 3 others. Circulation, 2026. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification. Papers, record 41587271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41587271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current and Future Treatments for Takayasu Arteritis: Toward Cardiovascular Risk Modification.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Takayasu Arteritis | Major topic |
| Immunosuppressive Agents | Major topic |
| Cardiovascular Diseases | Major topic |
| Humans | |
| Heart Disease Risk Factors | |
| Risk Factors | |
| Female | |
| Glucocorticoids | |
| Animals |
Source PubMed
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28811356 | Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis. | J Rheumatol | 2017 | https://conductscience.org/library/papers/28811356 | PubMed |
| 2 | 24511407 | Diagnosis and assessment of disease activity in takayasu arteritis: a childhood case illustrating the challenge. | Case Rep Rheumatol | 2014 | https://conductscience.org/library/papers/24511407 | PubMed |
| 3 | 24375298 | Optimizing the outcome of vascular intervention for Takayasu arteritis. | Br J Surg | 2014 | https://conductscience.org/library/papers/24375298 | PubMed |
| 4 | 37560375 | Common Autoantibody among Takayasu Arteritis and Ulcerative Colitis: A Possible Pathophysiology That Includes Gut-Vessel Connection in Vascular Inflammation. | JMA J | 2023 | https://conductscience.org/library/papers/37560375 | PubMed |
| 5 | 30824260 | Statins reduce relapse rate in Takayasu arteritis. | Int J Cardiol | 2019 | https://conductscience.org/library/papers/30824260 | PubMed |
| 6 | 17332971 | Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. | Clin Rheumatol | 2007 | https://conductscience.org/library/papers/17332971 | PubMed |
| 7 | 38669786 | Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis. | Semin Arthritis Rheum | 2024 | https://conductscience.org/library/papers/38669786 | PubMed |
| 8 | 35126357 | Identification of the Association Between Toll-Like Receptors and T-Cell Activation in Takayasu's Arteritis. | Front Immunol | 2021 | https://conductscience.org/library/papers/35126357 | PubMed |
| 9 | 39183340 | 18F-FDG-PET/MR imaging to monitor disease activity in large vessel vasculitis. | Nat Commun | 2024 | https://conductscience.org/library/papers/39183340 | PubMed |
| 10 | 28385306 | Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28385306 | PubMed |
| 11 | 36977782 | Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. | Nat Rev Cardiol | 2023 | https://conductscience.org/library/papers/36977782 | PubMed |
| 12 | 29030659 | Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis. | Rheumatol Int | 2017 | https://conductscience.org/library/papers/29030659 | PubMed |
| 13 | 36351705 | 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/36351705 | PubMed |
| 14 | 37011578 | Increased arterial stiffness and accelerated atherosclerosis in Takayasu arteritis. | Semin Arthritis Rheum | 2023 | https://conductscience.org/library/papers/37011578 | PubMed |
| 15 | 33276814 | Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients. | Arthritis Res Ther | 2020 | https://conductscience.org/library/papers/33276814 | PubMed |
| 16 | 35354303 | Cerebrovascular Ischemic Events in Patients With Takayasu Arteritis. | Stroke | 2022 | https://conductscience.org/library/papers/35354303 | PubMed |
| 17 | 38416140 | Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38416140 | PubMed |
| 18 | 24640521 | Impaired endothelial function in patients with Takayasu's arteritis. | Acta Cardiol | 2014 | https://conductscience.org/library/papers/24640521 | PubMed |
| 19 | 28283361 | Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea - A nationwide, population-based study. | Int J Cardiol | 2017 | https://conductscience.org/library/papers/28283361 | PubMed |
| 20 | 34257320 | Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34257320 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42666711 | Childhood-Onset Takayasu Arteritis With Extensive Vascular Involvement: A Four-Decade Follow-Up Case Report. | Case Rep Rheumatol | 2026 | https://conductscience.org/library/papers/42666711 | PubMed |
| 42445657 | Secondary Hypertension and Renal Atrophy Unmasking Takayasu Arteritis With Renal Artery Stenosis. | Cureus | 2026 | https://conductscience.org/library/papers/42445657 | PubMed |
| 42399575 | Serum ferritin as a predictor of major adverse cardiovascular events in Takayasu arteritis: a two-center retrospective cohort study. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/42399575 | PubMed |
| 42305700 | Syncope as the Initial Presentation of Takayasu Arteritis in a 57-Year-Old Female: A Case Report and Literature Review. | Clin Case Rep | 2026 | https://conductscience.org/library/papers/42305700 | PubMed |
| 42125509 | Severe Neurovascular and Cardiovascular Manifestations of Takayasu Arteritis: A Case Series and Review of the Literature. | Cureus | 2026 | https://conductscience.org/library/papers/42125509 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| NOTCH1 | 4851 | PubTator's text mining | https://conductscience.org/library/genes/4851 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41587271
GET https://conductscience.org/api/papers/v1/41587271/references?page=2